Loading...

CNS Pharmaceuticals, Inc.

CNSPNASDAQ
Healthcare
Biotechnology
$8.59
$0.38(4.63%)

CNS Pharmaceuticals, Inc. CNSP Peers

See (CNSP) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
CNSP$8.59+4.63%4.6M0.01$801.26N/A
VRTX$472.27-0.98%121.3B-123.96-$3.81N/A
REGN$564.64-1.35%59.9B14.36$39.32+0.31%
SGEN$228.74-0.07%43.2B-57.19-$4.00N/A
ALNY$328.00+0.72%42.7B-155.32-$2.11N/A
ARGX$591.74+2.84%36.2B36.08$16.40N/A
BNTX$114.57-0.03%27.5B-30.88-$3.71N/A
RPRX$36.59+1.61%20.6B14.93$2.45+2.39%
SMMT$27.57-1.57%20.5B-81.09-$0.34N/A
BGNE$184.71+0.49%20.2B-22.55-$8.19N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

CNSP vs VRTX Comparison

CNSP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNSP stands at 4.6M. In comparison, VRTX has a market cap of 121.3B. Regarding current trading prices, CNSP is priced at $8.59, while VRTX trades at $472.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNSP currently has a P/E ratio of 0.01, whereas VRTX's P/E ratio is -123.96. In terms of profitability, CNSP's ROE is -3.85%, compared to VRTX's ROE of -0.06%. Regarding short-term risk, CNSP is more volatile compared to VRTX. This indicates potentially higher risk in terms of short-term price fluctuations for CNSP.

Stock Price Comparison

Loading...

Frequently Asked Questions

;